Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-β peptide

Journal of Neurochemistry

Volumn 100, Issue 2, 2007, Pages 458-467

  Yamin, Rina ^a   Bagchi, Sandipan ^a   Hildebrant, Rick ^a   Scaloni, Andrea ^b   Widom, Russell L ^a   Abraham, Carmela R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CNR   (Italy)

Author keywords

Acyl peptide hydrolase; Alzheimer's disease; Amyloid degradation

Indexed keywords

ACYLAMINO ACID RELEASING ENZYME; AMYLOID BETA PROTEIN; PEPTIDASE; PROLYL ENDOPEPTIDASE; SERINE PROTEINASE;

ARTICLE; BIOLOGICAL ACTIVITY; BRAIN; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME ISOLATION; ERYTHROCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; TANDEM MASS SPECTROMETRY;

ACYLTRANSFERASES; AMYLOID BETA-PROTEIN; ANIMALS; AUTORADIOGRAPHY; CELL LINE; CERCOPITHECUS AETHIOPS; CHOLINESTERASE INHIBITORS; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOFLUROPHATE; MUTATION; NEUROBLASTOMA; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE; TANDEM MASS SPECTROMETRY; TRANSFECTION; TRITIUM;

EID: 33845763797     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04251.x     Document Type: Article

References (39)

1. Bartlam M., Wang G., Yang H., Gao R., Zhao X., Xie G., Cao S., Feng Y. and Rao Z. (2004) Crystal structure of an acylpeptide hydrolase/esterase from Aeropyrum pernix K1. Structure 12, 1481-1488.
2. Blanc E., Toborek M., Mark R., Hennig B. and Mattson M. (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces appoptosis in vascular endothelial cells. J. Neurochem. 68, 1870-1881.
3. Carson J. and Turner A. (2002) β-amyloid catabolism: role for neprylisin (NEP) and other metallopeptidases? J. Neurochem. 81, 1-8.
4. Cook D. G., Leverenz J. B., McMillan P. J., Kulstad J. J., Ericksen S., Roth R. A., Schellenberg G. D., Jin L. W., Kovacina K. S. and Craft S. (2003) Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele. Am. J. Pathol. 162, 313-319.
5. Eckman E., Reed D. and Eckman C. (2001) Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme. J. Biol. Chem. 276, 24 540-24 548.
6. Fujino T., Tada T., Hosaka T., Beppu M. and Kikugawa K. (2000a) Presence of oxidized protein hydrolase in human cell lines, rat tissues, and human/rat plasma. J. Biochem. (Tokyo) 127, 307-313.
7. Fujino T., Watanabe K., Beppu M., Kikugawa K. and Yasuda H. (2000b) Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochemica Biophysica Acta 1478, 102-112.
8. Giardina T., Biagini A., Massey-Harroche D. and Puigserver A. (1999) Distribution and subcellular localization of acylpeptide hydrolase and acylase I along the Hog gastro-intestinal tract. Biochimie 81, 1049-1055.
9. Glenner G. and Wong C. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
10. Hu J., Igarashi A., Kamata M. and Nakagawa H. (2001) Angiotensin- converting enzyme degrades Alzheimer's amyloid β-peptide (Aβ); retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem. 276, 47 863-47 868.
11. Iwata N., Tsubuki S., Takaki Y. et al. (2000) Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: supression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
12. Jones W. and Manning J. (1985) Acylpeptide hydrolase activity from erythrocytes. Biochem. Biophys. Res. Commun. 126, 933-940.
13. Jones W. M., Manning L. R. and Manning J. M. (1986) Enzymic cleavage of the blocked amino terminal residues of peptides. Biochem. Biophys. Res. Commun. 139, 244-250.
14. Jones W., Scaloni A., Bossa F., Popowicz A. M., Schneewind O. and Manning J. M. (1991) Genetic relationship between acylpeptide hydrolase and acylase, two hydrolytic enzymes with similar binding but different catalytic specificities. Proc. Natl Acad. Sci. USA 88, 2194-2198.
15. Masters C., Simms G., Weinman N., Multhaup G., McDonald B. and Beyruther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4549.
16. Mehta P., Pirttila T., Patrick B., Barshatzky M. and Mehta S. (2001) Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid from patients with Alzheimer's disease. Neurosci. Lett. 304, 102-106.
17. Polgár L. (2002) The propyl oligopeptidase family. Cell Mol. Life Sci. 57, 349-362.
18. Raphel V., Giardina T., Guevel L., Perrier J., Dupuis L., Guo X. J. and Puigserver A. (1999) Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa. Biochemyca Biophysica Acta 1432, 371-381.
19. Richards P., Johnson M. K. and Ray D. E. (2000) Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 58, 577-583.
20. Rosenblum J. S. and Kozarich J. W. (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7, 496-504.
21. Scaloni A., Jones W. M., Barra D., Pospischil M., Sassa S., Popowicz A., Manning L. R., Schneewind O. and Manning J. M. (1992a) Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme. J. Biol. Chem. 267, 3811-3818.
22. Scaloni A., Jones W. M., Posppischil M., Sassa S., Schneewind O., Popowicz A. M., Bossa F., Graziano S. L. and Manning J. M. (1992b) Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell line. J. Lab. Clin. Med. 120, 546-552.
23. Scaloni A., Barra D., Jones W. M. and Manning J. M. (1994) Human acylpeptide hydrolase studies on its thiol groups and mechanism of action. J. Biol. Chem. 269, 15 076-15 084.
24. Schoneich C. (2005) Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim. Biophys. Acta 1703, 111-119.
25. Shimizu K., Fujino T., Ando K., Hayakawa M., Yasuda H. and Kikugawa K. (2003) Overexpression of oxidized protein hydrolase protect COS-7 cells from oxidative stress-induced inhibition of cell growth and survival. Biochem. Biophys. Res. Commun. 304, 766-771.
26. Shimizu K., Kiuchi Y., Ando K., Hayakawa M. and Kikugawa K. (2004) Coordination of oxidized protein hydrolase and the proteosome in the clearance of cytotoxic denatured proteins. Biochem. Biophys. Res. Commun. 324, 140-146.
27. Sokolik C., Chyau Liang T. and Wold F. (1994) Studies on the specificity of acetylaminoacyl-peptide hydrolase. Protein Sci. 3, 126-131.
28. Song E.-S. and Hersh L. (2005) Insulysin: an allosteric enzyme as target for Alzheimer's disease. J. Mol. Neurosci. 25, 201-206.
29. Song E.-S., Juliano M., Juliano L. and Hersh L. (2003) Substrate activation of insulin-degrading enzyme (insulysin), a potential target for drug development. J. Biol. Chem. 278, 49 789-49 794.
30. Tsunasawa S. and Sakiyama F. (1984) Amino-terminal acetylation of proteins: an overview. Meth. Enzymol. 106, 165-170.
31. Tsunasawa S., Narita K. and Ogata K. (1975) Purification and properties of acylamino acid-releasing enzyme from rat liver. J. Bio-Chem. (Tokyo) 77, 89-102.
32. Tucker H. M., Kihiko M., Caldwell J. N. et al. (2000) The plasmin system is induced by and degrades amyloid-β aggregates. J. Neurosci. 20, 3937-3946.
33. Van Nostrand W. and Porter M. (1999) Plasmin cleavage of the amyloid β-protein: alteration of the secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 38, 11 570-11 576.
34. Varadarajan S., Kanski J., Aksenova M., Lauderback C. and Butterfield D. A. (2001) Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ1-42 and Aβ25-35. J. Am. Chem. Soc. 123, 5625-5631.
35. Vekrellis K., Ye Z., Qiu W., Walsh D., Hartley D., Chesneau V., Rosner M. and Selkoe D. (2000) Neurons regulate extracellular levels of amyloid β protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20, 1657-1665.
36. Weller R. (2002) Cerebrovascular disease is a major factor in the failure of elimination of Aβ from the aging human brain. Ann. N. Y. Acad. Sci. 977, 162-168.
37. Yamin R., Malgeri E. G., Sloane J. A., McGraw W. T. and Abraham C. R. (1999) Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation. J. Biol. Chem. 274, 18 777-18 784.
38. Yankner B., Duffy L. and Kirschner D. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptide. Science 250, 279-282.
39. Yasojima K., Akiyama H., McGeer E. G. and McGeer P. L. (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of βeta-amyloid peptide. Neurosci. Lett. 297, 97-100.